211 related articles for article (PubMed ID: 33227710)
1. Capilliposide B blocks VEGF-induced angiogenesis in vitro in primary human retinal microvascular endothelial cells.
Han H; Yang Y; Wu Z; Liu B; Dong L; Deng H; Tian J; Lei H
Biomed Pharmacother; 2021 Jan; 133():110999. PubMed ID: 33227710
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.
Palanisamy K; Nareshkumar RN; Sivagurunathan S; Raman R; Sulochana KN; Chidambaram S
Microvasc Res; 2019 Mar; 122():136-145. PubMed ID: 30144414
[TBL] [Abstract][Full Text] [Related]
3. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
5. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
7. PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling.
Huang SW; Lien JC; Kuo SC; Huang TF
Br J Pharmacol; 2014 Dec; 171(24):5728-42. PubMed ID: 25091695
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic effect of quercetin and its 8-methyl pentamethyl ether derivative in human microvascular endothelial cells.
Lupo G; Cambria MT; Olivieri M; Rocco C; Caporarello N; Longo A; Zanghì G; Salmeri M; Foti MC; Anfuso CD
J Cell Mol Med; 2019 Oct; 23(10):6565-6577. PubMed ID: 31369203
[TBL] [Abstract][Full Text] [Related]
9. Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling.
Wang QQ; Zhou SJ; Meng ZX; Wang J; Chen R; Lv L; Li CJ; Yu DM; Yu P
Mol Med Rep; 2015 Mar; 11(3):2167-72. PubMed ID: 25405610
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
11. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells.
Park BC; Thapa D; Lee JS; Park SY; Kim JA
J Pharmacol Sci; 2009 Sep; 111(1):1-12. PubMed ID: 19763043
[TBL] [Abstract][Full Text] [Related]
13. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo.
Zhang Y; Hu G; Li S; Li ZH; Lam CO; Hong SJ; Kwan YW; Chan SW; Leung GP; Lee SM
Mol Med Rep; 2012 Mar; 5(3):805-11. PubMed ID: 22179585
[TBL] [Abstract][Full Text] [Related]
14. NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells.
Watari K; Shibata T; Fujita H; Shinoda A; Murakami Y; Abe H; Kawahara A; Ito H; Akiba J; Yoshida S; Kuwano M; Ono M
Commun Biol; 2020 Mar; 3(1):107. PubMed ID: 32144393
[TBL] [Abstract][Full Text] [Related]
15. Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation.
Huang X; Zhou G; Wu W; Ma G; D'Amore PA; Mukai S; Lei H
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1228-1236. PubMed ID: 28241310
[TBL] [Abstract][Full Text] [Related]
16. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
17. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
18. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
19. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
[TBL] [Abstract][Full Text] [Related]
20. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
